Clinical trial
Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients.
NCT03644303
Study timeline
Study start (actual)2018-08-13Date precision: day
Registry last updated2026-05-14
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Metastasisunresolved
Toxicity Due to Radiotherapyunresolved
Circulating Tumour DNAunresolved
Interventions
SBRT + ADTRADIATION
Sponsors & collaborators
Royal Marsden NHS Foundation Trustlead sponsor
Prostate Cancer UKcollaborator
University College, Londoncollaborator
The Christie NHS Foundation Trustcollaborator
The Leeds Teaching Hospitals NHS Trustcollaborator
Velindre NHS Trustcollaborator
Newcastle-upon-Tyne Hospitals NHS Trustcollaborator
Belfast Health and Social Care Trustcollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03644303 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.